Literature DB >> 6442644

Immunomodulation by surface components of Listeria monocytogenes: a review.

S B Galsworthy.   

Abstract

Surface components of bacteria make the initial contact with host defence mechanisms. Such components from Listeria monocytogenes have been studied in attempts to elucidate mechanisms of pathogenicity. The cell walls of different serotypes of L. monocytogenes have been reported to contain abundant peptidoglycan, teichoic acid, lipoteichoic acid, endotoxin, and lipopeptidopolysaccharide. Cell walls are B cell mitogens in vivo and in vitro, fix complement, are chemotaxigenic and decrease resistance to infection with Listeria. A soluble, high molecular weight immunosuppressive agent is also a B cell mitogen in vitro. It induces an inflammatory response and a population of suppressor macrophages in vivo. Monocytosis-producing activity is a low molecular weight material associated with the cell membrane. It induces a labile, transient endogenous mediator and causes a 3-6 fold elevation in blood monocyte levels 48 h after injection. Mice genetically sensitive to Listeria infection fail to produce or respond to the endogenous monocytosis-inducing factor. The potential use of these factors in diagnosis of Listeria and in unravelling interrelationships in host defense mechanisms is discussed.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6442644

Source DB:  PubMed          Journal:  Clin Invest Med        ISSN: 0147-958X            Impact factor:   0.825


  2 in total

1.  Comparison of responsiveness to the monocytosis-producing activity of Listeria monocytogenes in mice genetically susceptible or resistant to listeriosis.

Authors:  S B Galsworthy; D Fewster
Journal:  Infection       Date:  1988       Impact factor: 3.553

2.  Lipoteichoic acid fractions from pathogenic and apathogenic Listeria species and Staphylococcus aureus induce similar amounts of macrophage-derived cytokines.

Authors:  T Nichterlein; M Kretschmar; G J Ruhland; F Fiedler; H Hof
Journal:  Inflammopharmacology       Date:  1997       Impact factor: 4.473

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.